- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-24-0049360

About Mars Remedies Private Limited
Data last updated:
Mars Remedies Private Limited is a private limited company based in Waghodia, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 November 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1999PTC036869. Its GSTIN is 24AABCM9227D1ZQ (Gujarat).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.84 Cr. It is led by directors including Mahmadyusuf Karbhari Abdulla (Whole-Time Director) and Azeem Karbhari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 635 G.I.D.C. Estate Waghodia, Gujarat, India – 391760.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.89 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹34.02 Lakh (net margin 2.9%) and EBITDA of ₹1.62 Cr (EBITDA margin 13.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 13% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mars Remedies. As per MCA filings, the company has open charges of ₹8.6 Cr and satisfied charges of ₹6.25 Cr on record. Court records list 44 cases involving the company, including 7 filed by the company and 37 filed against it; 14 cases are pending. The company has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹4 Cr; the latest was in March 2017. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Samay Pharma India Private Limited with revenue of ₹11.93 Cr.
Mars Remedies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0049360). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website marsremedies.com.
Company details
Recognitions & Rankings of Mars Remedies
Contact details
Mars Remedies Private Limited's registered office is in Waghodia, Gujarat. Its website is marsremedies.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address635 G.I.D.C. Estate Waghodia, Gujarat, India – 391760
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mars Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mars Remedies operates one associated brand: Mars Remedies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and contract services in India. | marsremedies.com |
Business activity
The main business activity of Mars Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mars Remedies Private Limited, buy the company report.
Financials of Mars Remedies Private Limited
FY 2025 filings availableMars Remedies Private Limited reported revenue of ₹11.89 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 10% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.62 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.7% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mars Remedies Private Limited, buy the company report.
Board of directors of Mars Remedies Private Limited
Mars Remedies has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahmadyusuf Karbhari Abdulla Also directs: Pharmadent Remedies Private Limited | Whole-Time Director | 09 Dec 2002 | 23 Years 10 Months | Current |
| Azeem Karbhari | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Tasleem Karbhari Also directs: Pharmadent Remedies Private Limited | Director | 05 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Mars Remedies Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Samay Pharma India Private Limited | ₹11.93 Cr (FY 2025) | 2.0% | Delhi, India | |||
| Ridge Formulations Private Limited | ₹11.89 Cr (FY 2025) | -5.0% | Solan, Himachal Pradesh, India | |||
| Mars Remedies Private Limitedthis company | ₹11.89 Cr (FY 2025) | ₹34.02 Lakh | 2.9% | 10.0% | 10 | Waghodia, Gujarat, India |
| Tidal Laboratories Private Limited | ₹11.87 Cr (FY 2025) | 34.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mars Remedies Private Limited, buy the company report.
Auditor
Mars Remedies Private Limited is audited by MAHESH VYAS & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAHESH VYAS & CO | FY 2024 | 105832W |
Shareholding
The shareholding of Mars Remedies Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mars Remedies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 May 2024 | 100939448 | Uco Bank | ₹4.3 Cr | Open | |
| 15 Mar 2024 | 100939466 | Uco Bank | ₹4.3 Cr | Open | |
| 30 Jul 2022 | 100632851 | Hdfc Bank Limited | ₹2.55 Cr | Satisfied | |
| 08 Jan 2013 | 10399772 | Others | ₹1.58 Cr | Satisfied | |
| 07 Jan 2013 | 10401343 | Others | ₹1.87 Cr | Satisfied |
To see the full charge records of Mars Remedies Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Mars Remedies Private Limited has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹4 Cr; the latest was in March 2017.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Funding round | ₹1.5 Cr | Investors: VN Capital Services LLP |
| Apr 2016 | Secondary share transfer | Undisclosed | Buyer: Pharmadent Remedies Private Limited , Indo Pharma Limited & Tasleem M Karbhari, Indo Pharma Limited & Mohammed Yusuf Karbhari Seller: 4 individuals |
| Sep 2015 | Funding round | ₹1 Cr | Investors: Pharmadent Remedies Private Limited , 3 individuals |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2012 | Funding round | ₹86.2 Lakh | Investors: 4 individuals |
To see the full deal history of Mars Remedies Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mars Remedies Private Limited has 44 court cases on record: 7 filed by Mars Remedies, 37 filed against it. 14 cases are pending and 30 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 29 | 25 | 5 |
| NCLAT | 12 | 12 | 7 |
| Supreme Court | 2 | 0 | 2 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 44)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Vrundavan Residency Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed against the company by Vrundavan Residency Private Limited | Pending |
| District court, Anand, Gujarat | Criminal complaint | Filed against the company by Vishal J.Patel As A On Behalf Director of Vrundavan Residency Pvt.Ltd | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Del Trade International Pvt Ltd | Pending |
| NCLAT, Chairperson Court | Tribunal matter | Filed against the company by BDH Industries Limited | Pending |
To see the full case history of Mars Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mars Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mars Remedies Private Limited has a workforce of 10 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
GST
Mars Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCM9227D1ZQ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mars Remedies Private Limited, buy the company report.
Recent activity
Mars Remedies Private Limited has 9 board changes on record since 2002: 3 appointments and 6 cessations. The latest: Tasleem Karbhari was appointed as Director on 05 Sep 2024.
14 earlier events are in the company report.
Frequently asked questions
Mars Remedies is an active private limited company based in Waghodia, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 November 1999 (27+ years old) and is registered under CIN U24231GJ1999PTC036869.
Mars Remedies has 3 current directors:
- Mahmadyusuf Karbhari Abdulla - Whole-Time Director
- Azeem Karbhari - Director
- Tasleem Karbhari - Director
The latest financial statements of Mars Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mars Remedies is 24AABCM9227D1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Mars Remedies is U24231GJ1999PTC036869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mars Remedies has 44 court cases on record: 7 filed by the company and 37 filed against it. 14 are pending. Most are in the district courts.
Mars Remedies was incorporated on 05 November 1999, making it 27+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Mars Remedies has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹4 Cr; the latest was in March 2017.
The peers of Mars Remedies by revenue are Samay Pharma India Private Limited, Ridge Formulations Private Limited, Tidal Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tasleem Karbhari was appointed as Director on 05 Sep 2024. Azeem Karbhari was appointed as Director on 01 Apr 2024. Tasleem Karbhari ceased to be Director on 01 Apr 2024. Mars Remedies has 9 board changes on record in total.
Yes, Mars Remedies is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0049360).

